Statin use in the US for secondary prevention of cardiovascular disease remains suboptimal

Q Ngo-Metzger, S Zuvekas, P Shafer… - The Journal of the …, 2019 - Am Board Family Med
Background: Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of
mortality in the United States. The purpose of this study is to examine the rates of statin use …

[PDF][PDF] Statin Use in the US for Secondary Prevention of Cardiovascular Disease Remains Suboptimal

Q Ngo-Metzger, S Zuvekas, P Shafer, AS Bierman - scholar.archive.org
Background: Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of
mortality in the United States. The purpose of this study is to examine the rates of statin use …

Statin Use in the US for Secondary Prevention of Cardiovascular Disease Remains Suboptimal.

Q Ngo-Metzger, S Zuvekas, P Shafer… - Journal of the …, 2019 - europepmc.org
Background Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of
mortality in the United States. The purpose of this study is to examine the rates of statin use …

Statin Use in the US for Secondary Prevention of Cardiovascular Disease Remains Suboptimal

Q Ngo-Metzger, S Zuvekas, P Shafer… - Journal of the …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of
mortality in the United States. The purpose of this study is to examine the rates of statin use …

Statin Use in the US for Secondary Prevention of Cardiovascular Disease Remains Suboptimal

Q Ngo-Metzger, S Zuvekas, P Shafer, AS Bierman - Am Board Family Med
Background: Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of
mortality in the United States. The purpose of this study is to examine the rates of statin use …